First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis.
作者信息
Kounis Nicholas G, Koniari Ioanna, Mplani Virginia, Plotas Panagiotis, Tsigkas Grigorios
机构信息
Department of Cardiology, University of Patras Medical School, 7 Aratou Street, Queen Olgas Square, 26221, Patras, Greece.
Department of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.
出版信息
J Clin Immunol. 2022 May;42(4):736-737. doi: 10.1007/s10875-022-01228-2. Epub 2022 Feb 17.
Abstract
摘要
相似文献
1
First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis.辉瑞 - 生物科技公司mRNA新冠疫苗（BNT162b2，Comirnaty）首剂接种后首例致命性暴发性嗜酸性粒细胞性心肌炎：一种与超敏反应或药物性心肌炎不同的极其罕见的特发性坏死性超敏反应。
J Clin Immunol. 2022 May;42(4):736-737. doi: 10.1007/s10875-022-01228-2. Epub 2022 Feb 17.
2
First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction.首例辉瑞-生物科技 mRNA COVID-19 疫苗（BNT162b2，Comirnaty）初始剂量后致命性暴发性嗜酸性粒细胞性心肌炎：一种极其罕见的特发性过敏反应。
J Clin Immunol. 2022 Apr;42(3):441-447. doi: 10.1007/s10875-021-01187-0. Epub 2022 Jan 3.
3
Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech).辉瑞-生物科技 COVID-19 疫苗（BNT162b2，即 托珠单抗）接种后心肌炎引起的室性心动过速。
Pacing Clin Electrophysiol. 2022 Sep;45(9):1097-1100. doi: 10.1111/pace.14486. Epub 2022 Apr 4.
4
Myocarditis after BNT162b2 vaccination in a healthy male.健康男性接种 BNT162b2 疫苗后出现心肌炎。
Am J Emerg Med. 2021 Dec;50:815.e1-815.e2. doi: 10.1016/j.ajem.2021.06.051. Epub 2021 Jun 29.
5
Fulminant myocarditis with complete atrioventricular block after mRNA COVID-19 vaccination: A case report.新型冠状病毒肺炎（COVID-19）mRNA疫苗接种后暴发性心肌炎伴完全性房室传导阻滞：一例报告
J Cardiol Cases. 2023 May;27(5):229-232. doi: 10.1016/j.jccase.2023.01.004. Epub 2023 Jan 27.
6
A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.接种首剂 COVID-19 mRNA 疫苗后出现心肌炎并伴有高回声结节 1 例
J Korean Med Sci. 2022 Apr 25;37(16):e131. doi: 10.3346/jkms.2022.37.e131.
7
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.儿童系列病例中，心肌炎与 BNT162b2 信使 RNA COVID-19 疫苗相关。
JAMA Cardiol. 2021 Dec 1;6(12):1446-1450. doi: 10.1001/jamacardio.2021.3471.
8
Post-COVID mRNA vaccine myocarditis in children: report of two cases.儿童感染新冠病毒后的 mRNA 疫苗心肌炎：两例报告。
BMJ Case Rep. 2022 Nov 28;15(11):e253383. doi: 10.1136/bcr-2022-253383.
9
Pathogenic Variants of Scavenger Receptor Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19).清道夫受体的致病变体导致噬菌作用降低，并在接种辉瑞 - 生物科技公司的BNT162b2疫苗预防冠状病毒感染（COVID - 19）后易患心肌炎。
Circulation. 2024 Jan 16;149(3):270-273. doi: 10.1161/CIRCULATIONAHA.123.064884.
10
STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine.STEMI 类表现：mRNA 新冠疫苗接种后青少年患者的局灶性心肌炎。
J Emerg Med. 2021 Dec;61(6):e129-e132. doi: 10.1016/j.jemermed.2021.09.017. Epub 2021 Sep 27.
引用本文的文献
1
The Epidemiology of COVID-19 Vaccine-Induced Myocarditis.新型冠状病毒肺炎疫苗诱导的心肌炎的流行病学
Adv Med. 2024 Apr 18;2024:4470326. doi: 10.1155/2024/4470326. eCollection 2024.
2
Reader comments.读者评论。
Proc (Bayl Univ Med Cent). 2022 Apr 29;35(4):579-580. doi: 10.1080/08998280.2022.2057181. eCollection 2022.
本文引用的文献
1
Hypersensitivity myocarditis.过敏性心肌炎
Ann Allergy. 1989 Feb;62(2):71-4.
Zotero 插件